Cargando…

Uso de la anticoncepción con solo gestágenos en atención primaria: estudio GESTAGAP

AIM: To estimate the prevalence of use of progestin-only contraceptive among women who request reversible contraception in Primary Care (PC). DESIGN: Multicentre cross-sectional study. SETTING: Primary Care Health Care Centres (Madrid). PARTICIPANTS: Women aged 16-50 years old, users of reversible c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Rodríguez, Raquel, Polentinos-Castro, Elena, Azcoaga-Lorenzo, Amaya, González-Fernández, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6837132/
https://www.ncbi.nlm.nih.gov/pubmed/30115450
http://dx.doi.org/10.1016/j.aprim.2018.05.005
Descripción
Sumario:AIM: To estimate the prevalence of use of progestin-only contraceptive among women who request reversible contraception in Primary Care (PC). DESIGN: Multicentre cross-sectional study. SETTING: Primary Care Health Care Centres (Madrid). PARTICIPANTS: Women aged 16-50 years old, users of reversible contraception, who speak Spanish, and had attended the Primary Care Centre in the last year. MAIN MEASUREMENTS: Primary outcome: contraceptive method used: Contraception with progestins-only (yes/no). Age, parity, country of origin, type of contraceptive method used, reason for choice, source of information, satisfaction with the contraceptive method. Telephone survey. RESULTS: A total of 417 women were interviewed. The median age was 30.3 years (SD: 7.7). Spanish 69%, and 82% of participants had secondary or university studies. More than half (57%) were nulliparous. The type of contraceptive used included: progestins only: 14%, combined hormonal contraceptive: 74%, copper IUD: 2%, and condom 10%. The prevalence of use of “progestins-only” was 13.9% (95% CI: 10.6-17.2). Medroxyprogesterone acetate injection was the most progestin-only method used (4.6%), desogestrel oral pill (4.1%), IUD-levonorgestrel IUD (3.9%), and etonogestrel subdermal implant (1.9%). The family doctor was the prescriber in 71% of the women. Satisfaction: high (range 9-10). Using only progestogens was associated with older age, being non-Spanish, breastfeeding, and having a medical contraindication for combined contraception (P < 0.05). CONCLUSIONS: The prevalence of use for progestins was 14%, satisfaction was very high for all contraceptive methods. The user profile for the only progestins-only corresponds to older, and non-Spanish women with conditions such as breastfeeding or contraindications for other contraceptives.